Literature DB >> 21642649

Pharmacokinetics of the raltegravir/maraviroc/etravirine combination.

Andrea Calcagno, Silvia Nozza, Stefano Bonora, Antonella Castagna, Daniel Gonzalez de Requena, Antonio D'Avolio, Adriano Lazzarin, Giovanni Di Perri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21642649     DOI： 10.1093/jac/dkr219

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  2 in total

1.  Biotransformation of the antiretroviral drug etravirine: metabolite identification, reaction phenotyping, and characterization of autoinduction of cytochrome P450-dependent metabolism.

Authors:  Lindsay J Yanakakis; Namandjé N Bumpus
Journal:  Drug Metab Dispos       Date:  2012-01-23       Impact factor: 3.922

2.  Nanoparticle Encapsulation for Antiretroviral Pre-Exposure Prophylaxis.

Authors:  Karl Khandalavala; Subhra Mandal; Rachel Pham; Christopher J Destache; Annemarie Shibata
Journal:  J Nanotechnol Mater Sci       Date:  2017-08-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.